The IPO Window Is Opening

31 March 2010 Publication
Authors: Paul D. Broude

MX: Medtech Executive

Foley Partner Paul Broude authored an article titled “The IPO Window Is Opening” in the March 2010 issue of MX: Medtech Executive. Broude examines the reasons for a device company to consider an initial public offering for its growth plans, stating that 2010 may bring the promise of IPOs for medical device companies to fund clinical trials, regulatory approvals, and the protection of the company’s intellectual property. He adds that going public enables some medical device and life science companies to continue growing while creating an exit vehicle for management and other shareholders.


Telehealth: Medicare Finalizes New Services for 2020 in Physician Fee Schedule
11 November 2019
Health Care Law Today
Longstanding EB-5 Visa Program Undergoes Significant Changes
11 November 2019
Labor & Employment Law Perspectives
State Data Breach Notification Laws
11 November 2019
DOJ Announces Procurement Collusion Strike Force
08 November 2019
Legal News: Government Enforcement Defense & Investigations
PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
Fall NAIC Meeting Reception
07 December 2019
Austin, TX